The experiments proposed here address potential mechanisms of cocaine action in the central nervous system, with a particular emphasis on some of the brain regions which appear to be implicated in the reinforcing effects of cocaine (e.g. nucleus acumbens (NAS), frontal cortex (FC)). The basic hypothesis on which these studies are based is that the action of cocaine are not entirely explicable in terms of its ability to inhibit the neuronal re-uptake of dopamiine (DA) and norepinephrine (NE), since other drugs with greater potencies in inhibiting DA and NE re-uptake in corpus striatum do not appear to share the reinforcing properties of cocaine. One possibility is that there are significant differences between the drug sensitivities of the DA re-uptake systems in the brain regions mediating cocaine reinforcement and those of the corpus striatum. Possible alternative mechanisms of action include direct stimulation of DA release in NAS and FC, indirect stimulation of DA release by inhibition of the action of presynaptic regulators of DA release such as DA itself or cholescystokinin (CCK-8S) which is co-localized with DA in rat NAS, or modulation of the postsynaptic actions of DA. We, therefore, propose to characterize DA uptake systems in brain preparations from NAS, FC and CS from bovine and rat with respect to drug sensitivity in each brain region, and to attempt the solubilization and purification of cocaine binding proteins from these regions of bovine brain for use in the development of tools for the further study of the uptake systems. We will also evaluate the ability of cocaine to stimulate DA release in NAS and FC slice and synaptosome preparations. Finally, the possibility that postsynaptic actions of DA might be affected by cocaine, either acting directly or by affecting a regulatory function of CCK-8S will be studied. The effects of cocaine and CCK-8S on DA binding to D2 and D1 type binding sites, and on DA regulation of adenylate cyclase in these tissues will be studied.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA004953-02
Application #
3210808
Study Section
(SRCD)
Project Start
1988-04-01
Project End
1991-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
2
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Henry M. Jackson Fdn for the Adv Mil/Med
Department
Type
DUNS #
City
Rockville
State
MD
Country
United States
Zip Code
20852
Romualdi, P; D'Addario, C; Ferri, S et al. (2001) Chronic GBR 12909 administration differentially alters prodynorphin gene expression compared to cocaine. Eur J Pharmacol 413:207-12
Azaryan, A V; Clock, B J; Rosenberger, J G et al. (1998) Transient upregulation of mu opioid receptor mRNA levels in nucleus accumbens during chronic cocaine administration. Can J Physiol Pharmacol 76:278-83
Noble, F; Cox, B M (1997) The role of dopaminergic systems in opioid receptor desensitization in nucleus accumbens and caudate putamen of rat after chronic morphine treatment. J Pharmacol Exp Ther 283:557-65
Buzas, B; Rosenberger, J; Cox, B M (1996) Mu and delta opioid receptor gene expression after chronic treatment with opioid agonist. Neuroreport 7:1505-8
Noble, F; Cox, B M (1996) Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors. Brain Res 716:107-17
Noble, F; Cox, B M (1996) Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Br J Pharmacol 117:161-9
Noble, F; Cox, B M (1995) Differential regulation of D1 dopamine receptor- and of A2a adenosine receptor-stimulated adenylyl cyclase by mu-, delta 1-, and delta 2-opioid agonists in rat caudate putamen. J Neurochem 65:125-33
Unterwald, E M; Cox, B M; Kreek, M J et al. (1993) Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse 15:33-8